Adaptive Biotechnologies (ADPT) Return on Equity (2019 - 2025)
Historic Return on Equity for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q3 2025 value amounting to 0.41%.
- Adaptive Biotechnologies' Return on Equity rose 4300.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year increase of 4300.0%. This contributed to the annual value of 0.62% for FY2024, which is 400.0% down from last year.
- According to the latest figures from Q3 2025, Adaptive Biotechnologies' Return on Equity is 0.41%, which was up 4300.0% from 0.66% recorded in Q2 2025.
- In the past 5 years, Adaptive Biotechnologies' Return on Equity registered a high of 0.21% during Q1 2021, and its lowest value of 0.84% during Q3 2024.
- In the last 5 years, Adaptive Biotechnologies' Return on Equity had a median value of 0.44% in 2022 and averaged 0.52%.
- In the last 5 years, Adaptive Biotechnologies' Return on Equity plummeted by -3600bps in 2024 and then skyrocketed by 4300bps in 2025.
- Quarter analysis of 5 years shows Adaptive Biotechnologies' Return on Equity stood at 0.33% in 2021, then decreased by -27bps to 0.42% in 2022, then crashed by -60bps to 0.67% in 2023, then dropped by -11bps to 0.75% in 2024, then soared by 45bps to 0.41% in 2025.
- Its Return on Equity stands at 0.41% for Q3 2025, versus 0.66% for Q2 2025 and 0.72% for Q1 2025.